Quick Answer
Ocean Biomedical, Inc. reported Net Income of -$9.48 million for fiscal year 2024.
Ocean Biomedical, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$9.48M | +91.7% |
| 2023 | -$114.47M | -559.4% |
| 2022 | -$17.36M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$8.24M | -163.4% | -49.1% |
| September 30, 2024 | -$5.53M | +60.8% | +67.9% |
| June 30, 2024 | -$17.23M | -50.8% | -232.6% |
| March 31, 2024 | $13.00M | +118.0% | +192.3% |
| September 30, 2023 | -$14.09M | -284.1% | -23.2% |
| June 30, 2023 | -$11.43M | -55.9% | +84.1% |
| March 31, 2023 | -$72.09M | -1241.2% | -1865.4% |
| September 30, 2022 | -$3.67M | -8521.5% | +50.0% |
- Ocean Biomedical, Inc. showed an increase of +91.7% in Net Income compared to the prior fiscal year.
- Over the 2022–2024 period, Ocean Biomedical, Inc.’s net income has grown by 45.4% (from -$17.36 million to -$9.48 million).
- The most recent figure is from Ocean Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: